NCT00884728
Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory No drug interventions Not Available Not Available completed NCT00330642
Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study No drug interventions Not Available Not Available withdrawn NCT01026636
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age basic_science 1 completed NCT01156740
Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource Settings treatment Not Available completed NCT01026740
Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers basic_science 1 completed NCT04841369
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) prevention 3 completed NCT03055728
Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis No drug interventions Not Available Not Available completed NCT00261742
Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis treatment 4 terminated NCT01026558
A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients basic_science 1 completed NCT00646958
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections treatment 2 completed NCT00299663
Long Term Follow-up of Patients With Group A Streptococcal Infection Originating From the Genital Tract No drug interventions Not Available Not Available completed NCT01193920
Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age No drug interventions prevention 1 / 2 completed NCT01030731
Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease basic_science 1 completed NCT02052973
Efficacy of Propolis Varnish Against Oral Biofilm No drug interventions prevention 1 / 2 completed NCT00514527
A Study for Patients With Complicated Skin and Skin Structure Infections treatment 2 completed NCT00598429
Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure treatment 2 withdrawn NCT02270944
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine treatment 2 completed NCT01412801
Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings No drug interventions prevention 2 completed NCT04100772
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above prevention 1 completed NCT00169481
A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine No drug interventions prevention 2 completed NCT01118143
Oral Health Literacy Tailored Communication No drug interventions prevention Not Available completed NCT00527852
Assessment of Flocked Swabs for the Identification of Group A Streptococcal Pharyngitis No drug interventions diagnostic Not Available completed NCT00001658
Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections treatment 4 completed NCT01446289
Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings No drug interventions prevention 2 completed NCT02972281
Systematic Search for Primary Immunodeficiency in Adults With Infections No drug interventions diagnostic Not Available terminated NCT02899702
Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children treatment 4 withdrawn NCT00001359
Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup) No drug interventions treatment 2 completed NCT01365390
To Evaluate the Incidence of Acute Otitis Media in Children in Five East European Countries No drug interventions Not Available Not Available completed NCT00896064
Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults No drug interventions prevention 2 completed NCT01641133
Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™ prevention 3 completed NCT00307554
A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study No drug interventions prevention 3 completed NCT00466947
COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine prevention 3 completed NCT00707798
Evaluation of Pneumococcal Vaccine Formulations in Young Adults prevention 1 completed NCT01175083
Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A prevention 3 completed NCT01153893
Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria prevention 3 completed NCT02838407
Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain. No drug interventions other Not Available completed NCT01204385
Study to Identify and Characterize the Bacteria Causing Acute Otitis Media Episodes in Young Children in Saudi Arabia No drug interventions Not Available Not Available completed NCT02447432
A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants prevention 3 completed NCT01616459
Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants prevention 2 completed NCT00523770
Exploratory Study in Healthy Elderly Subjects to Collect Urine for Development of Assays to Detect S. Pneumoniae No drug interventions Not Available Not Available completed NCT01485406
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers prevention 1 completed NCT00624819
Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine prevention 3 completed NCT01153841
Primary Vaccination Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Vietnam prevention 3 completed NCT00307541
Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine No drug interventions prevention 3 completed NCT00334334
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine. No drug interventions prevention 3 completed NCT00370396
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine. prevention 3 completed NCT01204658
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants prevention 2 completed NCT00345358
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine prevention 3 completed NCT01030822
Booster and Catch-up Vaccination With Vaccine GSK1024850A No drug interventions prevention 3 completed NCT01119625
Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose prevention 3 completed NCT01793857
Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in Panama No drug interventions Not Available Not Available completed NCT00861380
Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease prevention 3 completed NCT00911144
Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same Vaccine prevention 3 completed NCT00808444
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age prevention 3 completed NCT00678301
Primary Vaccination Course in Children Receiving the Pneumococcal Vaccine GSK 1024850A, Zilbrix™ Hib and Polio Sabin™ prevention 3 completed NCT00390910
Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants prevention 3 completed NCT00829010
Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. prevention 3 completed NCT00950833
Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children No drug interventions prevention 3 completed NCT00489554
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age prevention 3 completed NCT00839254
Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A prevention 3 completed NCT00652951
Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib prevention 3 completed NCT00985751
Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination No drug interventions prevention 2 completed NCT00637351
A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays No drug interventions Not Available Not Available completed NCT00907777
Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™ No drug interventions prevention 3 completed NCT01027845
Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children prevention 3 completed NCT01046097
Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines Not Available Not Available terminated NCT01248988
Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea No drug interventions Not Available Not Available completed NCT00513409
Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule prevention 2 completed NCT00792909
Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A No drug interventions prevention 3 completed NCT00496015
Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A prevention 3 completed NCT01545375
Evaluation of a Vaccine for Reducing Ear and Lung Infections in Children prevention 2 completed NCT01235949
Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment prevention 4 completed NCT00344318
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine prevention 3 completed NCT00307034
Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule prevention 3 completed NCT00547248
Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines prevention 3 completed NCT00985465
Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali No drug interventions prevention 3 completed NCT00327665
Study to Evaluate the Safety and Immunogenicity of an Investigational Pneumococcal Vaccine in the Elderly Population prevention 1 completed NCT00370227
Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine No drug interventions prevention 3 completed NCT01031329
Study to Identify and Characterize Bacteria Causing Acute Otitis Media in Young Children in Turkey No drug interventions Not Available Not Available withdrawn NCT00609492
Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. prevention 3 completed NCT00756067
Evaluation of Pneumococcal Vaccine Formulations in Elderly prevention 1 completed NCT01262872
Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants prevention 2 completed NCT00814710
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age prevention 3 completed NCT00680914
Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™ prevention 3 completed NCT01160055
Study to Characterize and Identify Bacteria Causing Acute Otitis Media in Young Egyptian Children No drug interventions Not Available Not Available withdrawn NCT00333450
Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines. No drug interventions prevention 3 completed NCT01746108
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection prevention 3 completed